首页 >> 师资队伍 >> 正高 >> 正文

丁振华

职称:二级教授,博士生导师,博士后合作导师

通讯地址:广州市南方医科大学公共卫生学院放射医学系

Email: dingzh@smu.edu.cn

最高学历:博士

所属科室:放射医学系

扩展字段01 职称:二级教授,博士生导师,博士后合作导师 扩展字段02 通讯地址:广州市南方医科大学公共卫生学院放射医学系
扩展字段03 Email: dingzh@smu.edu.cn 扩展字段04 最高学历:博士
扩展字段05 所属科室:放射医学系

学术任职:

广东省医学会放射防护医学分会主任委员,中华医学会放射医学与防护专业委员会常委,广东省社会学会常委等

研究方向:

1.miRNA在细胞应激反应信号转导中的调节作用;2.放射卫生与放射防护技术;3.核与放射事

科研项目:

近三年负责课题

国家自然科学基金(30970673、81172634);

广东省自然科学基金(9151022501000013);

教育部博士点基金项目(20094433110004)。等。

成果奖励:

近三年没有成果和奖励。

代表论文:

一、主编、参编多部学术著作,共110万字。

二、主要论文

1.Ding Zhenhua, et al. Inhibitory effect of china green tea polyphenol on the oxidative modification of low density lipoprotein by macrophage. Med Sci Res 1991; 19(22):767-768

2.Ding Z, Parchment RE, LoRusso PM, et al. The investigational new drug XK469 induces G2-M cell cycle arrest by p53-dependent and –independent pathways.Clin Cancer Res 2001;7:3336

3.Wu GS & Ding Z. Caspase 9 is required for p53-dependent apoptosis and chmosensitivity in a human ovarian cencer cell line. Oncogene 2002; 21(1):1

4.Zhenhua Ding, Jun-Ying Zhou, Wei-Zen Wei, Vicki V Baker and Gen Sheng Wu. Induction of apoptosis by the new anticancer drug XK469 in human ovarian cancer cell lines. Oncogene 2002;21:4530

5.Jing Jiao, Hong Cao, Zhen-hua Ding.EJGH 2007;19(12):1114

6.Ling Guo, Zhong-Xi Huang, Xiao-Wei Chen, Qin-Kai Deng and Zhen-Hua Ding.Photochem Photobiol, 2009; 85: 765

7.Fang Gao, Xiaoqun Duan, Xi Lu, Yongming Liu, Li Zheng, Zhenhua Ding, Jun Li. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry. BBRC, 2010; 391:952

8.Mei-Juan ZHOU, Wei-Ling LIU, Ling GUO, Li ZHENG, Chao LV, Li-Hong JIANG, Cheng-Shan OU and Zhen-Hua DING.Differential Responses to UVB Irradiation in Human Keratinocytes and Epidermoid Carcinoma Cells1. Biomed Envirm Sci,2012;21(5):583

9.Meijuan Zhou; Weilin Liu; Shudong Ma; Hong Cao;Xuebiao Peng; Ling Guo; Xinghua Zhou; Li Zhen; Linlang Guo; Miaojian Wan; Weimin Shi; Yingjie He; Chao Lu;Lihong Jiang; Chenshan Ou; Yuanxia Guo; Zhenhua Ding.A Novel OncomiR-365 Induces Cutaneous Squamous Cell Carcinoma.Carcinogenesis, 2013; 34(7):1653

10.Meijuan Zhou, Liang Zhou, Li Zheng, Ling Guo, Yinghui Wang, Hongxia Liu, Chengshan Ou & Zhenhua Ding.miR-365 Promotes Cutaneous Squamous Cell Carcinoma (CSCC) through Targeting Nuclear Factor I/B (NFIB).PLoSONE,2014;E96):e100620.doi:10.1371/journal.pone.0100620